CGPI Insider Trading Activity and SEC Form 4 Filings
CGPI insider trading summary
No open-market insider purchases or sales of Collagenex Pharmaceuticals Inc (CGPI) have been reported on SEC Form 4 in the past 12 months.
Latest CGPI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 4, 2008 | David F Pfeiffer | Sr. VP, Sales and Marketing | Sell | $82K (6,667 @ $12.28) |
| Jan 28, 2008 | David F Pfeiffer | Sr. VP, Sales and Marketing | Sell | $12K (1,000 @ $11.81) |
| Jan 28, 2008 | David F Pfeiffer | Sr. VP, Sales and Marketing | Sell | $65K (5,503 @ $11.80) |
| Jan 28, 2008 | David F Pfeiffer | Sr. VP, Sales and Marketing | Sell | $2K (164 @ $11.83) |
| Jan 22, 2008 | David F Pfeiffer | Sr. VP, Sales and Marketing | Sell | $73K (6,666 @ $10.88) |
| Nov 28, 2007 | Andrew Kenneth William Powell | VP, G. Counsel and Corp. Sec. | Buy | $1K (200 @ $7.30) |
| Nov 28, 2007 | Klaus Theobald | Sr VP & Chief Medical Officer | Buy | $8K (1,050 @ $7.41) |
| Nov 27, 2007 | Klaus Theobald | Sr VP & Chief Medical Officer | Buy | $2K (300 @ $7.41) |
| Nov 20, 2007 | James Gregory Ford | VP, Business Development | Buy | $12K (1,500 @ $7.87) |
| Nov 20, 2007 | Klaus Theobald | Sr VP & Chief Medical Officer | Buy | $7K (860 @ $7.75) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.